In addition, relatives of men with a pathogenic germline variant in one of the genes that are related to breast cancer in women (BRCA1, BRCA2, ATM, CHEK2, PALB2) might benefit from genetic testing of the index patient. This evidence concerns the gene BRCA2 and breast carcinoma.